Skip to main content
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1994 Feb;144(2):215–220.

Simultaneous interphase cytogenetic analysis and fluorescence immunophenotyping of dedifferentiated chondrosarcoma. Implications for histopathogenesis.

J A Bridge 1, J DeBoer 1, J Travis 1, S L Johansson 1, G Elmberger 1, S M Noel 1, J R Neff 1
PMCID: PMC1887143  PMID: 8311109

Abstract

Cytogenetic analysis of four specimens (biopsy, definitive surgical, and two separately occurring lung metastases) of a dedifferentiated chondrosarcoma with a rhabdomyosarcomatous component revealed clonal karyotypic abnormalities in each. Anomalies seen in all specimens included a structurally aberrant chromosome 17 and extra copies of chromosomes 5, 7, 12, and 20. The derivation of the chromosomally abnormal cells was determined by a combined immunocytochemical/cytogenetic approach that allowed simultaneous assessment of cytogenetic aberrations and immunophenotypic features of individual cells. S-100 protein and desmin antibodies were used to evaluate the chondrosarcomatous and rhabdomyosarcomatous components, respectively. A chromosome 7-specific centromeric probe was used for determination of aneuploidy. In both specimens obtained from the primary lesion, S-100 protein and desmin-positive and -negative aneuploid cells were observed. These findings: 1) suggest that both the chondrocytic and rhabdomyoblastic cells arose from the same abnormal clone, 2) support the theory of a common primitive mesenchymal cell progenitor with the ability to differentiate or express features of more than one line of mesenchymal differentiation, and 3) indicate that the term dedifferentiated may be an inaccurate designation for this neoplasm.

Full text

PDF
215

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anastasi J. Interphase cytogenetic analysis in the diagnosis and study of neoplastic disorders. Am J Clin Pathol. 1991 Apr;95(4 Suppl 1):S22–S28. [PubMed] [Google Scholar]
  2. Bridge J. A., Bhatia P. S., Anderson J. R., Neff J. R. Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genet Cytogenet. 1993 Sep;69(2):79–90. doi: 10.1016/0165-4608(93)90080-6. [DOI] [PubMed] [Google Scholar]
  3. Bridge J. A., Sreekantaiah C., Mouron B., Neff J. R., Sandberg A. A., Wolman S. R. Clonal chromosomal abnormalities in desmoid tumors. Implications for histopathogenesis. Cancer. 1992 Jan 15;69(2):430–436. doi: 10.1002/1097-0142(19920115)69:2<430::aid-cncr2820690226>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  4. Dahlin D. C., Beabout J. W. Dedifferentiation of low-grade chondrosarcomas. Cancer. 1971 Aug;28(2):461–466. doi: 10.1002/1097-0142(197108)28:2<461::aid-cncr2820280227>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  5. Fletcher J. A., Pinkus G. S., Weidner N., Morton C. C. Lineage-restricted clonality in biphasic solid tumors. Am J Pathol. 1991 May;138(5):1199–1207. [PMC free article] [PubMed] [Google Scholar]
  6. Weber-Matthiesen K., Winkemann M., Müller-Hermelink A., Schlegelberger B., Grote W. Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. J Histochem Cytochem. 1992 Feb;40(2):171–175. doi: 10.1177/40.2.1552161. [DOI] [PubMed] [Google Scholar]
  7. Zalupski M. M., Ensley J. F., Ryan J., Selvaggi S., Baker L. H., Wolman S. R. A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcoma. Cancer. 1990 Sep 15;66(6):1176–1182. doi: 10.1002/1097-0142(19900915)66:6<1176::aid-cncr2820660617>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES